Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	7.61	34.78	32.32
Graham Fair Price	95.47	32.86	16.81
PEG	-99.85	< 0.005	-1.98
Price/Book	82.80	6.46	3.54
Price/Cash Flow	57.54	41.79	26.53
Prices/Earnings	-84.85	-2.24	14.76
Price/Sales	-0.92	8.98	9.07
Price/FCF	57.54	41.79	26.53
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-1.04	0.75	0.76
Operating Margin	31.19	0.19	0.15
ROA	549.56	-0.12	0.02
ROE	0.06	-0.72	1106.46
ROIC	0.03	0.03	27.82
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.38	0.06	587.31
Dividends QOQ	-0.01	0.05	253.65
EBIT QOQ	-0.33	0.36	7.06
EPS QOQ	-0.07	-7.77	-10334.15
FCF QOQ	-0.11	-0.35	-216.71
Revenue QOQ	0.05	0.03	-27.45
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	87.28	91.63	4.98
Days Sales Outstanding (DSO)	119.70	106.65	-10.90
Inventory Turnover	1.03	0.98	-4.75
Debt/Capitalization	0.58	0.78	32.82
Quick Ratio	1.24	0.92	-25.72
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	14.48	8.15	-43.72
Cash	6.04	4.78	-20.91
Capex	-0.16	-0.14	13.56
Free Cash Flow	1.93	1.26	-34.70
Revenue	5.65	5.87	3.83
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.43	1.11	-22.20
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	7.23	10.81	49.49
Naive Interpretation	Member

06 - Financial Health · Bad

Rating